Papp, K.A., Merola, J.F., Gottlieb, A.B. and al., E. 2018. Dual neutralization of IL-17A and IL-17F with bimekizumab improves quality of life in patients withmoderate-to-severe plaque psoriasis: results from a Phase 2b study and correlation with clinical response. SKIN The Journal of Cutaneous Medicine. 2, (Dec. 2018), S92. DOI:https://doi.org/10.25251/skin.2.supp.93.